Enzolytics Inc (ENZC)

[bigtalan]

They were spread out during various months and years depending on what it was related to , most of the filings are mentioned in PR's

https://finance.yahoo.com/news/enzolytics-announces-international-patent-office-103000840.html

PLANO, TX / ACCESSWIRE / December 10, 2020 / Enzolytics, Inc. (OTC PINK:ENZC or the "Company") today announced the filing of a provisional patent with the U.S. Patent Office on December 9, 2020 for a treatment of Multiple Sclerosis developed by Harry Zhabilov, titled NUCLEAR PROTEINS ISOLATED FROM MAMALIAN SPINAL CORD (SCNP) IMMUNE FACTOR, S er. No. 62/123341.

Enzolytics, Inc. has an aggressive strategy to cover its intellectual property. The company has the following issued U.S. patents covering its technology relating to a peptide that has been demonstrated in clinical trials to provide anti-HIV-1 retroviral benefit in vivo 1:

U.S. Patent No. 7,479,538, issued January 20, 2009, entitled Irreversibly-Inactivated Pepsinogen Fragment and Pharmaceutical Compositions Comprising the Same for Detecting, Preventing and Treating HIV.
U.S. Patent No. 8,066,982, issued November 29, 2011, entitled Irreversibly-Inactivated Pepsinogen Fragment and Pharmaceutical Compositions Comprising the Same for Detecting, Preventing, and Treating HIV.
Enzolytics also owns a proprietary cell line producing Clone 3 anti-HIV monoclonal antibody 1. The company has pending international patent applications covering the use of any of its discovered numerous conserved Coronavirus epitopes or conserved HIV epitopes in the production of monoclonal antibodies, the production of vaccines or use in diagnostic tests for detecting the viruses in patients 2.

https://finance.yahoo.com/news/enzolytics-announces-discovery-patenting-8-130000732.html

https://finance.yahoo.com/news/enzolytics-announces-progress-development-patenting-110000381.html

its not hard to look it up GLTA